Bezitramide

Bezitramide

Clinical data
Routes of administration	Oral
ATC code	N02AC05 (WHO)
Legal status
Legal status	US: Schedule II
Identifiers
IUPAC name 4-[4-(2-oxo-3-propanoyl-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]-2,2-diphenylbutanenitrile
CAS Number	15301-48-1
PubChem CID	61791
DrugBank	DB01459 Y
ChemSpider	55675 Y
UNII	3KXW0Y310I
ChEMBL	ChEMBL2104149
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C31H32N4O2
Molar mass	492.611 g/mol
3D model (JSmol)	Interactive image
SMILES O=C(N2c1ccccc1N(C2=O)C5CCN(CCC(C#N)(c3ccccc3)c4ccccc4)CC5)CC
InChI InChI=1S/C31H32N4O2/c1-2-29(36)35-28-16-10-9-15-27(28)34(30(35)37)26-17-20-33(21-18-26)22-19-31(23-32,24-11-5-3-6-12-24)25-13-7-4-8-14-25/h3-16,26H,2,17-22H2,1H3 Y Key:FLKWNFFCSSJANB-UHFFFAOYSA-N Y
(verify)

WikiDoc Resources for Bezitramide
Articles
Most recent articles on Bezitramide Most cited articles on Bezitramide Review articles on Bezitramide Articles on Bezitramide in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Bezitramide Images of Bezitramide Photos of Bezitramide Podcasts & MP3s on Bezitramide Videos on Bezitramide
Evidence Based Medicine
Cochrane Collaboration on Bezitramide Bandolier on Bezitramide TRIP on Bezitramide
Clinical Trials
Ongoing Trials on Bezitramide at Clinical Trials.gov Trial results on Bezitramide Clinical Trials on Bezitramide at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Bezitramide NICE Guidance on Bezitramide NHS PRODIGY Guidance FDA on Bezitramide CDC on Bezitramide
Books
Books on Bezitramide
News
Bezitramide in the news Be alerted to news on Bezitramide News trends on Bezitramide
Commentary
Blogs on Bezitramide
Definitions
Definitions of Bezitramide
Patient Resources / Community
Patient resources on Bezitramide Discussion groups on Bezitramide Patient Handouts on Bezitramide Directions to Hospitals Treating Bezitramide Risk calculators and risk factors for Bezitramide
Healthcare Provider Resources
Symptoms of Bezitramide Causes & Risk Factors for Bezitramide Diagnostic studies for Bezitramide Treatment of Bezitramide
Continuing Medical Education (CME)
CME Programs on Bezitramide
International
Bezitramide en Espanol Bezitramide en Francais
Business
Bezitramide in the Marketplace Patents on Bezitramide
Experimental / Informatics
List of terms related to Bezitramide

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Bezitramide is an opioid analgesic. Bezitramide itself is a prodrug which is readily hydrolyzed in the gastrointestinal tract to its main metabolite, despropionyl-bezitramide. Bezitramide was discovered at Janssen Pharmaceutica in 1961. It is most commonly marketed under the trade name Burgodin.

The drug was pulled from the shelves in the Netherlands in 2004 after fatal overdose cases, including one where a five-year-old child took one tablet from his mother's purse, ate it, and promptly died.

Bezitramide is regulated much the same as morphine in all known jurisdictions and is a Schedule II substance under the United States' Controlled Substances Act of 1970, with an ACSCN of 9800 and zero annual manufacturing quota. However, it has to this point never been marketed in the United States.